JAMA Cardiology

DECEMBER 19, 2023

This post hoc analysis of the Ticagrelor vs Clopidogrel in Stabilized Patients With Acute Myocardial Infarction (TALOS-AMI) randomized clinical trial investigates the efficacy and safety of the de-escalation strategy of switching from ticagrelor to clopidogrel vs dual antiplatelet therapy with ticagrelor in stabilized patients with acute myocardial (..)

Myocardial Infarction 79

Myocardial Infarction 79

Nature Reviews - Cardiology

MAY 2, 2024

Nature Reviews Cardiology, Published online: 03 May 2024; doi:10.1038/s41569-024-01031-z In the AEGIS-II trial, infusion of apolipoprotein A-I to increase cholesterol efflux capacity did not improve outcomes in patients with acute myocardial infarction.

Myocardial Infarction 69

Myocardial Infarction Cholesterol Outcomes 69

American College of Cardiology

OCTOBER 29, 2024

The goal of the CLEAR SYNERGY OASIS 9 trial was to determine the long-term cardiovascular (CV) effects of colchicine following percutaneous coronary intervention (PCI) for ST-segment elevation or large non–ST-segment elevation myocardial infarction (STEMI or NSTEMI, respectively).

Myocardial Infarction 68

Myocardial Infarction STEMI Article 68

Frontiers in Cardiovascular Medicine

NOVEMBER 25, 2024

IntroductionCardiovascular diseases include myocardial infarction, a high mortality disease. Myocardial infarction patients are becoming younger, typically defined as patients under 45 years of age. We searched the WoSCC between 1980 and 2023 for research papers and reviews on myocardial infarction in youth.

Myocardial Infarction 59

Myocardial Infarction Research Academic 59

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background The diagnosis of a left ventricular (LV) thrombus in patients with ST-segment elevation myocardial infarction (STEMI) remains challenging. The aim of the current study is to characterize clinical predictors for LV thrombus formation, as detected by cardiac magnetic resonance imaging (CMRI). and 59%, respectively.

Myocardial Infarction 80

Myocardial Infarction STEMI Hospital 80

HCPLive

APRIL 12, 2024

Ankeet Bhatt, MD, MBA, discusses a NUDGE-FLU analysis from ACC.24 24 examining effect of the CV gain-framed nudge in patients with and without history of AMI.

Myocardial Infarction 119

Myocardial Infarction 119

JAMA Cardiology

JUNE 17, 2024

This genetic association study evaluated genetic variants associated with increased risk of vasospastic angina.

Angina 104

Angina Myocardial Infarction 104

American College of Cardiology

APRIL 7, 2024

The goal of the REDUCE-AMI trial was to evaluate the potential benefit of beta-blockade following acute myocardial infarction (AMI) in patients with preserved left ventricular ejection fraction (LVEF) in the modern era of coronary revascularization and medical therapy.

Myocardial Infarction 66

Myocardial Infarction Article 66

American College of Cardiology

NOVEMBER 17, 2024

The goal of the CLEAR SYNERGY (OASIS 9) spironolactone trial was to determine the potential cardiovascular (CV) benefit of spironolactone following percutaneous coronary intervention (PCI) for ST-segment or large non–ST-segment elevation myocardial infarction (STEMI or NSTEMI, respectively) regardless of post-MI left ventricular ejection fraction (..)

Myocardial Infarction 56

Myocardial Infarction STEMI Article 56

Cardiovascular Diabetology

MAY 26, 2024

Stress hyperglycemia, which is associated with poor prognosis in patients with acute myocardial infarction (AMI), can be determined using the stress hyperglycemia ratio (SHR). Impaired left ventricular functio.

Myocardial Infarction 78

Myocardial Infarction Research 78

Cardiovascular Diabetology

JANUARY 21, 2024

It is well-known that systemic inflammation plays a crucial role in the pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune-inflammation index (SII, platelet × neutrophil/lymph.

Myocardial Infarction 72

Myocardial Infarction Diabetes Research 72

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

Despite improvements in clinical outcomes of acute myocardial infarction (AMI), mortality rates remain high, indicating the need for further understanding of the pathogenesis and developing more effective cardiac protection strategies.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Physiology Innovation 52

American College of Cardiology

DECEMBER 2, 2024

Current guidelines regarding beta-blocker use after myocardial infarction (MI) recommend against continuation to improve outcomes after 1 year, in the absence of reduced left ventricular ejection fraction (LVEF; <50%) or other primary indications for therapy.

Myocardial Infarction 51

Myocardial Infarction Outcomes Article 51

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundCardiac rupture (CR) after acute myocardial infarction (AMI) is a fatal mechanical complication. The early identification of factors related to CR in high-risk cases may reduce mortality. and in-hospital mortality was approximately 57%.

Myocardial Infarction 59

Myocardial Infarction Risk Factors Hospital 59

Med Page Today

JUNE 26, 2024

(MedPage Today) -- Influenza infection was associated with an increased risk of acute myocardial infarction (MI), especially for those without a prior hospitalization for coronary artery disease (CAD), according to a Dutch observational case series.

Heart attacks 143

Heart attacks Heart Attack Coronary Artery Disease Myocardial Infarction 143

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

Multiple logistic regression and restricted cubic spline (RCS) analyses were conducted to assess both linear and nonlinear associations between WWI and myocardial infarction. Subgroup analyses and interaction tests were also performed.ResultsAmong the 31,535 participants analyzed, 1,449 (4.82%) had experienced a myocardial infarction.

Myocardial Infarction 59

Myocardial Infarction BMI Angina Obesity 59

American College of Cardiology

NOVEMBER 7, 2024

The goal of the PACMAN-AMI trial was to demonstrate the efficacy of early administration of alirocumab on plaque characteristics among patients undergoing percutaneous coronary intervention (PCI) for an acute myocardial infarction (AMI).

Myocardial Infarction 60

Myocardial Infarction Atherosclerosis Plaque Article 60

Medical Xpress - Cardiology

OCTOBER 30, 2024

The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization.

Myocardial Infarction 52

Myocardial Infarction Ischemia Outcomes Strokes 52

Frontiers in Cardiovascular Medicine

NOVEMBER 12, 2024

ObjectiveThis study aimed to investigate the causal relationship between insomnia and the risk of myocardial infarction (MI) and explore potential mediators such as smoking initiation, alcohol consumption and body mass index (BMI) using mendelian randomization (MR) analysis.MethodsData from 1,207,228 individuals of European ancestry were obtained from (..)

Myocardial Infarction 59

Myocardial Infarction BMI 59

JAMA Cardiology

SEPTEMBER 1, 2024

This post hoc analysis of a randomized clinical trial analyzes imaging data for atheroma volume at the lesion level from patients who received intensive lipid-lowering therapy with alirocumab plus statin compared with a statin alone.

Myocardial Infarction 96

Myocardial Infarction 96

The New England Journal of Medicine

MAY 29, 2024

A 70-year-old woman with diabetes presented with epigastric pain and vomiting. ECG showed normal sinus rhythm with pathologic Q waves and T-wave inversions in the anterior leads. Ventriculography and echocardiography are shown in videos.

Myocardial Infarction 75

Myocardial Infarction Diabetes 75

Cardiovascular Diabetology

AUGUST 15, 2024

Diabetes mellitus (DM) and coronary microvascular dysfunction (CMD) increase the risk of adverse cardiac events in patients with non-ST-segment elevation myocardial infarction (NSTEMI). This study aimed to eva.

Myocardial Infarction 59

Myocardial Infarction Diabetes Research 59

Cardiovascular Diabetology

SEPTEMBER 2, 2024

Despite the detrimental impact of abnormal glucose metabolism on cardiovascular prognosis after myocardial infarction (MI), diabetes is both underdiagnosed and undertreated. We investigated associations betwee.

Myocardial Infarction 59

Myocardial Infarction Diabetes Cardiac Rehabilitation Research 59

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

While gadolinium-based contrast agents are the gold standard for identifying myocardial infarction (MI), their use is limited in patients with allergies or impaired kidney function, affecting a significant portion of the MI population. Cardiovascular magnetic (CMR) resonance is a versatile tool for diagnosing cardiovascular diseases.

Myocardial Infarction 52

Myocardial Infarction Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

BackgroundInflammation significantly impacts chronic kidney disease (CKD) and acute myocardial infarction (AMI).

Myocardial Infarction 52

Myocardial Infarction Kidney Disease Risk Factors Hospital 52

American College of Cardiology

AUGUST 30, 2024

The goal of the ABYSS trial was to evaluate beta-blocker interruption compared with beta-blocker continuation after an uncomplicated myocardial infarction (MI).

Myocardial Infarction 54

Myocardial Infarction Hospital Article 54

NEJM Journal Watch - Cardiology

OCTOBER 8, 2024

It's probably 9 g/dL in patients with MI and anemia.

Myocardial Infarction 81

Myocardial Infarction 81

Frontiers in Cardiovascular Medicine

JULY 22, 2024

IntroductionIn developing countries, there is a notable scarcity of real-world data on adherence to optimal medical therapy (OMT) and its correlation with major cardiovascular adverse events (MACEs) after ST-elevation myocardial infarction (STEMI). Patients were followed up for 4.5 ResultsWe included 349 patients with a mean age of 58.08

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

Cardiovascular Diabetology

APRIL 26, 2024

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been suggested to exert cardioprotective effects in patients with heart failure, possibly by improving the metabolism of ketone bodies in the myocardium.

Myocardial Infarction 105

Myocardial Infarction Heart Failure Research 105

Cardiovascular Diabetology

OCTOBER 29, 2024

Type 2 diabetes has traditionally been a risk factor for worse prognosis after myocardial infarction (MI), but major advances have been made in its treatment, and the use of secondary preventive measures has i.

Myocardial Infarction 52

Myocardial Infarction Diabetes Risk Factors Research 52

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

Therefore, this meta-analysis aimed to estimate association between TMAO levels and the prognosis of patients with myocardial infarction (MI).MethodsWe However, the relationships between TMAO adverse cardiovascular events are inconsistent in patients. were systematically addressed.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Heart Failure Strokes 52

Frontiers in Cardiovascular Medicine

DECEMBER 3, 2024

However, whether immediate blood glucose and FIB levels affect coronary blood flow during primary percutaneous coronary intervention (PCI) remains unclear.ObjectiveTo explore the correlation between admission blood glucose (ABG), fibrinogen (FIB) and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction (STEMI).MethodsA

Myocardial Infarction 52

Myocardial Infarction STEMI Risk Factors Hospital 52

Med Page Today

FEBRUARY 21, 2024

(MedPage Today) -- For the first time, intravascular imaging-guided coronary stenting was associated with better survival and reduced myocardial infarction (MI) in a meta-analysis powered to detect these benefits against angiography, researchers.

Myocardial Infarction 110

Myocardial Infarction Stent Stents Research 110

Cardiovascular Diabetology

JANUARY 5, 2024

Few studies explored the effect of the combination of glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on the incidence of cardiovascular events in pa.

Myocardial Infarction 106

Myocardial Infarction Diabetes Research 106

Med Page Today

NOVEMBER 18, 2024

(MedPage Today) -- CHICAGO -- Electronic nudges increased uptake of flu vaccines among patients with a history of acute myocardial infarction (MI), results from three Danish randomized trials showed. Among over 2 million patients, a letter explaining.

Myocardial Infarction 110

Myocardial Infarction 110

Med Page Today

OCTOBER 29, 2024

(MedPage Today) -- A Chinese study suggested that cold weather may make people more susceptible to myocardial infarction with non-obstructive coronary arteries compared with myocardial infarction from obstructive disease. European Heart Journal.

Heart attacks 92

Heart attacks Heart Attack Myocardial Infarction 92

NEJM Journal Watch - Cardiology

JULY 27, 2024

In a large observational study, patients who survived to three months had only slightly higher 10-year mortality compared with the general population.

Myocardial Infarction 80

Myocardial Infarction 80